Released: December 1, 2021
Expires: December 1, 2022
An informative webinar designed to meet the educational needs of neurology physicians, nurse practitioners, PAs, pharmacists, and other healthcare professionals involved in the care of patients living with MS.
Program Overview
This timely webinar provides an overview of the efficacy, safety, side effects, and immune system impact of MS disease-modifying therapies. Our distinguished faculty also discuss sequencing considerations, including vaccines, that can impact the choice of MS therapy for individuals living with MS.
With featured speakers:
Robert K. Shin, MD, FANA, FAAN
Professor, Department of Neurology
MedStar Georgetown University Hospital
Lori Mayer, DNP, NP-C, APRN, MSN, RN, MSCN
Assistant Medical Director
Elligo Research
Credit Designations
Physicians
The CMSC designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The CMSC designates this activity for a maximum of 1.0 contact hours of nursing continuing professional development (NCPD) (1.0 in the area of pharmacology)
Pharmacists
This knowledge-based activity, JA4008165-9999-21-017-H01-P, qualifies for 1.0 contact hours (.10 CEUs) of continuing pharmacy education credit.
This activity is jointly provided by The Consortium of Multiple Sclerosis Centers and Catamount Medical Education and is supported by an independent educational grant from Biogen.
